Open versus Robot-Assisted Radical Cystectomy: Pentafecta and Trifecta Achievement Comparison

What is it about?

This study compared open radical cystectomy (ORC) vs robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (iUD) from a randomised controlled trial (RCT). The primary endpoint of the trial was achieved with lower perioperative transfusion rates in the RARC cohort. The study found no statistically significant differences in USC pentafecta and trifecta achievement between the two groups. However, both 1-year USC pentafecta and trifecta achievement were predictors of 2-year unmodified global health-related quality of life (HRQoL).

Featured Image

Why is it important?

This research is important because it compares the outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (iUD) and open radical cystectomy (ORC) in patients with bladder cancer. The study finds that RARC-iUD and ORC have comparable outcomes, including perioperative transfusion rates, peri- and postoperative complication rates, and oncological outcomes. This provides evidence for the safety and feasibility of a totally intracorporeal robot-assisted approach, which may offer benefits over traditional open surgery. Key Takeaways: 1. RARC-iUD and ORC have comparable outcomes in terms of perioperative transfusion rates, peri- and postoperative complication rates, and oncological outcomes. 2. The robot-assisted approach with iUD is safe and feasible, offering potential benefits over traditional open surgery. 3. The study defines and uses the USC pentafecta and trifecta to assess surgical quality and patient outcomes, providing a strict correlation between objective evaluation of surgical outcomes and self-reported health-related quality of life (HRQoL).